• Changing the Guard

    Immuno-Oncology drives Pharma Licensing Strategy

    Celgene and Medivation have announced deals to acquire access to PD-1 inhibitors. The promise of immunotherapy is driving corporate strategy. Read More

  • Autumn Fall Colours

    Cancer Conferences to watch out for this fall

    Want to know which cancer cancer meetings we'll be at or writing about this autumn? Find Out

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

We help Pharma & Biotech companies understand the oncology market, and focus on the right target and commercial opportunity. We offer a range of services that are often combined into custom, hybrid projects:

We frequently work with new products people in prelaunch mode from preclinical to phase II, market researchers and CI teams.

Executive coaching is typically for staff at the Senior Director – Senior VP level who want to ask better strategic questions.